Literature DB >> 3113653

Successful treatment of infertility due to polycystic ovary disease using a combination of luteinising hormone releasing hormone agonist and low dosage menotrophin.

M Armitage, T Wilkin, K Dewbury.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3113653      PMCID： PMC1246970          DOI： 10.1136/bmj.295.6590.96

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  3 in total

1.  Endocrine effects of goserelin, a new depot luteinising hormone releasing hormone agonist.

Authors:  E J Thomas; J Jenkins; E A Lenton; I D Cooke
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-29

2.  Effect of high tonic levels of luteinising hormone on outcome of in-vitro fertilisation.

Authors:  C M Howles; M C Macnamee; R G Edwards; R Goswamy; P C Steptoe
Journal:  Lancet       Date:  1986-08-30       Impact factor: 79.321

Review 3.  Ovulatory disorders in women with polycystic ovary syndrome.

Authors:  S Franks; J Adams; H Mason; D Polson
Journal:  Clin Obstet Gynaecol       Date:  1985-09
  3 in total
  2 in total

Review 1.  Buserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical profile.

Authors:  R N Brogden; M M Buckley; A Ward
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

Review 2.  Gonadotrophin releasing hormone analogues for gynaecological disorders and infertility.

Authors:  H M Fraser; J Waxman
Journal:  BMJ       Date:  1989-02-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.